lobular breast carcinoma in situ
Showing 1 - 17 of 17
Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ Trial in
Recruiting
- Atypical Hyperplasia of the Breast
- +2 more
- Cancer Educational Materials
- +3 more
-
Costa Mesa, California
- +48 more
Jan 9, 2023
Breast Cancer, Node-positive Breast Cancer, Breast Adenocarcinoma Trial in Richmond, South Hill (External Beam Radiation
Active, not recruiting
- Breast Cancer
- +4 more
- External Beam Radiation Therapy
- +2 more
-
Richmond, Virginia
- +1 more
Dec 16, 2022
Benign Breast Tumor, Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma Trial in Boston, New York, Houston
Completed
- Benign Breast Neoplasm
- +11 more
- Docosahexaenoic Acid
- Placebo
-
Boston, Massachusetts
- +3 more
Dec 3, 2021
Treating Patients With Stage IV Breast Cancer
Active, not recruiting
- Central Nervous System Metastases
- +15 more
- hyperfractionated radiation therapy
- +2 more
-
North Chicago, IllinoisUniversity of Chicago
Dec 6, 2021
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,
Active, not recruiting
- BRCA1 Mutation Carrier
- +8 more
- soy isoflavones
- +7 more
-
Los Angeles, CaliforniaUniversity of Southern California
Nov 11, 2021
Breast Carcinoma, Ductal Breast Carcinoma In Situ, Hot Flashes Trial in United States (Oxybutynin Chloride, Placebo,
Completed
- Breast Carcinoma
- +4 more
- Oxybutynin Chloride
- +3 more
-
Peoria, Illinois
- +12 more
Jan 14, 2020
Ductal Breast Carcinoma in Situ, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in Philadelphia
Completed
- Ductal Breast Carcinoma in Situ
- +6 more
- Behavioral dietary intervention
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 4, 2019
Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Male Breast Cancer Trial in Winston-Salem (omega-3 fatty
Completed
- Ductal Breast Carcinoma in Situ
- +8 more
- omega-3 fatty acid
- +2 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Oct 7, 2019
Atypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Columbus (curcumin, Biomarker analysis,
Completed
- Atypical Ductal Breast Hyperplasia
- +4 more
- curcumin
- +3 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Aug 29, 2019
BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma In Situ Trial in West Hollywood, Chicago, New York
Unknown status
- BRCA1 Mutation Carrier
- +8 more
- Telapristone Acetate
- +3 more
-
West Hollywood, California
- +2 more
Aug 16, 2019
Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ Trial in Seattle (educational intervention, counseling
Completed
- Anxiety Disorder
- +10 more
- educational intervention
- +2 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 6, 2018
Ductal Breast Carcinoma In Situ, Estrogen Receptor Negative, Estrogen Receptor Positive Trial in Buffalo (procedure, radiation,
Terminated
- Ductal Breast Carcinoma In Situ
- +14 more
- Therapeutic Conventional Surgery
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jun 7, 2017
Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Recurrent Breast Cancer Trial (breast reconstruction,
Withdrawn
- Ductal Breast Carcinoma in Situ
- +9 more
- breast reconstruction
- intraoperative imaging
- (no location specified)
Apr 12, 2017
Atypical Ductal Breast Hyperplasia, Breast Cancer, Ductal Breast Carcinoma in Situ Trial in Houston (atorvastatin calcium,
Completed
- Atypical Ductal Breast Hyperplasia
- +3 more
- atorvastatin calcium
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Dec 28, 2016
Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Stage II Breast Cancer Trial in Canada, United States
Completed
- Ductal Breast Carcinoma in Situ
- +6 more
- Neoadjuvant Therapy
- +6 more
-
Washington, District of Columbia
- +7 more
Jun 1, 2016
Atypical Ductal Breast Hyperplasia, Atypical Lobular Breast Hyperplasia, BRCA1 Mutation Carrier Trial in Seattle (counseling
Completed
- Atypical Ductal Breast Hyperplasia
- +5 more
- counseling intervention
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jan 15, 2016
Healthy, no Evidence of Disease, Lobular Breast Carcinoma in Situ Trial in Tucson, Rochester (letrozole, quality-of-life
Completed
- Healthy, no Evidence of Disease
- Lobular Breast Carcinoma in Situ
- letrozole
- +2 more
-
Tucson, Arizona
- +2 more
Oct 17, 2014